► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs

AstraZeneca has won extended US approval for a pipeline drug but, as Lex's Oliver Ralph and Robert Armstrong discuss, it needs more good news to stem its patent expiration problem.
For more video content from the Financial Times, visit http://www.FT.com/video


Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes